Role of G308 promoter variant of tumor necrosis factor alpha gene on weight loss and metabolic parameters after a high monounsaturated versus a high polyunsaturated fat hypocaloric diets

Med Clin (Barc). 2013 Sep 7;141(5):189-93. doi: 10.1016/j.medcli.2012.12.021. Epub 2013 Apr 17.

Abstract

Background and objective: The aim of our study was to investigate the influence of G-308 promoter variant of the tumor necrosis factor (TNF) alpha gene on metabolic changes and weight loss secondary to a high monounsaturated fat vs a high polyunsaturated fat hypocaloric diet in obese subjects.

Patients and method: A sample of 261 obese subjects were enrolled in a consecutive prospective way, from May 2011 to July 2012 in a tertiary hospital. In the basal visit, patients were randomly allocated during 3 months to Diet M (high monounsaturated fat hypocaloric diet) and Diet P (high polyunsaturated fat hypocaloric diet).

Results: One hundred and ninety seven patients (73.2%) had the genotype G-308G and 64 (26.8%) patients had the genotype G-308A. There were no significant differences between the effects (on weight, body mass index (BMI), waist circumference, fat mass) in either genotype group with both diets. With the diet type P and in genotype G-308G, glucose levels (-6.7(22.1)mg/dl vs -3.7(2.2)mg/dl: p = 0.02), HOMA-R (-0.6(2.1)units vs -0.26(3.1)units: p = 0.01), insulin levels (-1.7(6.6)UI/L vs -0.6(7.1)UI/L: p = 0.009), total cholesterol levels (-15.3(31.1)mg/dl vs -8.4(22.1)mg/dl: p = 0.01), LDL cholesterol levels (-10.7(28.1)mg/dl vs -3.8(21.1)mg/dl: p = 0.008) and triglycerides (-12.1(52.1)mg/dl vs -6.6(43.1)mg/dl: p = 0.02) decreased.

Conclusion: Carriers of the G-308G promoter variant of TNF alpha gene have a better metabolic response than A-308 obese with a high polyunsaturated fat hypocaloric diet.

Keywords: Dieta hipocalórica; G308 TNF-alpha polymorphism; Hypocaloric diet; Obesidad; Obesity; Polimorfismo G-308 del factor de necrosis tumoral α.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adipokines / blood
  • Adult
  • Anthropometry
  • Blood Glucose / analysis
  • Blood Pressure
  • C-Reactive Protein / analysis
  • Cholesterol / blood
  • Combined Modality Therapy
  • Cytokines / blood
  • Diet, Reducing*
  • Dietary Fats / administration & dosage*
  • Exercise Therapy
  • Fatty Acids, Monounsaturated / administration & dosage*
  • Fatty Acids, Unsaturated / administration & dosage*
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Insulin / blood
  • Male
  • Middle Aged
  • Obesity / blood
  • Obesity / diet therapy
  • Obesity / genetics*
  • Obesity / therapy
  • Promoter Regions, Genetic / genetics*
  • Prospective Studies
  • Triglycerides / blood
  • Tumor Necrosis Factor-alpha / genetics*
  • Weight Loss / genetics*

Substances

  • Adipokines
  • Blood Glucose
  • Cytokines
  • Dietary Fats
  • Fatty Acids, Monounsaturated
  • Fatty Acids, Unsaturated
  • Insulin
  • Triglycerides
  • Tumor Necrosis Factor-alpha
  • C-Reactive Protein
  • Cholesterol